Bluerock Operations Limited company information, Employees & Contact Information

Bluerock Interval fund wins shareholder approval to start trading. InvestmentNews

Bluerock Value Exchange Launches $71 Million 1031 Exchange BR Diversified Industrial Portfolio 6 DST PR Newswire

Bayer-owned BlueRock lays off 50 employees, shutters Cambridge research labs Fierce Biotech

BlueRock TMS Expands North American Leadership with Appointment of Brent Wallace GlobeNewswire

Bluerock Total Income+ Real Estate Fund Celebrates its 50th Consecutive Quarterly Distribution Yahoo Finance

BlueRock accelerates Parkinson’s disease therapy to Phase III Clinical Trials Arena

BlueRock Therapeutics advances investigational cell therapy bemdaneprocel for treating Parkinson’s disease to registrational Phase III clinical trial Bayer

Bluerock Homes Trust: Encouraging Developments (Rating Upgrade) (NYSE:BHM) Seeking Alpha

After Bluerock falls short of investor votes to list fund, CEO asks for more. InvestmentNews

Bluerock Value Exchange Fully Subscribes $36.7 Million Diversified Industrial Portfolio V DST PR Newswire

BlueRock Therapeutics announces publication in Nature of 18-month data from Phase 1 clinical trial for bemdaneprocel, an investigational cell therapy for Parkinson’s disease GlobeNewswire

Bluerock seeks to list real estate fund with investors already heading for the exits. InvestmentNews

BlueRock Begins First Human Trial of iPSC Cell Therapy for Primary Photoreceptor Diseases Applied Clinical Trials

Here Is a Map of Every City in America That Willie Nelson Ever Sang About Texas Monthly

Bluerock Pays $103M for Tampa Community Multifamily Housing News

Bluerock interval fund could trade at “substantial discount” after it lists, company says. InvestmentNews

BlueRock Therapeutics and bit.bio announce collaboration and option agreement for the discovery and manufacture of regulatory T cell (Treg) based therapies Bayer

FDA approves BlueRock’s cell therapy IND for photoreceptor diseases trial Clinical Trials Arena

Bayer-bought BlueRock cuts 12% of workforce across 3 sites as pipeline contracts Fierce Biotech

Bluerock invests in Townsend for private wealth expansion as Aon sells firm InvestmentNews

First Parkinson’s disease patient treated in BlueRock’s GlobeNewswire

36-Month Phase I: BlueRock’s bemdaneprocel Shows Durable Safety and Motor Improvements Stock Titan

BlueRock Consulting launches the Luxury Hotel Benchmarking Report Hospitality Net

Bluerock Total Income+ Real Estate Fund Secures $750 Million Line of Credit with JPMorgan, RBC Capital Markets PR Newswire

Bayer subsidiary BlueRock taps Rune Labs for Parkinson's study software Fierce Biotech

BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial PR Newswire

Bluerock Appoints Doug Kinney as Managing Director citybiz

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy PR Newswire

Bayer christens $250M cell therapy 'launch facility' in Berkeley Fierce Pharma

Bluerock Value Exchange Launches $37.8 Million 1031 Exchange BR Churchill Downs Multifamily DST in Pinehurst, NC PR Newswire

Blackstone affiliates to buy Bluerock REIT in $3.6 bln deal Reuters

Fraggle Rock: 40 Years Later – “The Beast of Bluerock” ToughPigs

Blackstone concludes $3.6 billion acquisition of Bluerock Mortgage Professional America

Bluerock Homes Trust Completes Acquisition of Skytop Apartments TipRanks

BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases PR Newswire

Fortino Capital makes strategic investment in BlueRock TMS to help boost its international growth ambitions American Journal of Transportation

Bluerock buys second Lane Industrial Park building in Northwest Jacksonville Jacksonville Daily Record

Paragliders soar over Vallejo’s Blue Rock Springs The Vallejo Sun

Bayer to pay $240M to buy BlueRock cell therapy joint venture Fierce Biotech

Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy PMLiVE

Bayer to Acquire BlueRock Therapeutics for Up-to-$600M, with Cell Therapy Pipeline in Mind Genetic Engineering and Biotechnology News

Already Owning 40.8% of BlueRock Therapeutics, Bayer Buys Rest of Company for $600 Million BioSpace

Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes Business Wire

Bayer buys BlueRock in $600 million bet on stem cell therapies Reuters

This startup wants to regenerate the heart and brain to keep people healthier for longer businessinsider.com

BlueRock acquires specialist music & entertainment advisory White Sky Consultancy.com.au

Blackstone Buying Multifamily REIT Bluerock for $3.6B The Real Deal

Dutch company BlueRock TMS onboards Fortino Capital as an investor: Here’s why Silicon Canals

BlueRock Horizon Asset Management: Marcus Erikson Unveils Tech-Driven Strategy ACCESS Newswire

BlueRock adds Arthur Advisory as it pursues capital partner Consultancy.com.au

BlueRock adds directors to R&D and government incentives team Consultancy.com.au

Man arrested after high-speed motorcycle chase ends in Mt. Airy WLWT

Ophir hops onto BlueRock’s register; expands into unlisted markets AFR

The Blue Rock of Antioch KQED

BlueRock appoints Ella Morse, Trevor Gordijn and Bevan McLeod Consultancy.com.au

Pharmaceutical company Bayer AG acquiring BlueRock Therapeutics for US$1-billion The Globe and Mail

Financial services firm BlueRock facing $3m in directors’ dismissal claims AFR

Works at Bluerock Projects’ Tuohy Garden Apartments progressing BTR News Australia

Mountain unicycling? Extreme sport 'a thrill' for Calgary man CTV News